SK285326B6 - Orálna dávková forma obsahujúca omeprazol a S-omeprazol, spôsob jej prípravy a jej použitie - Google Patents

Orálna dávková forma obsahujúca omeprazol a S-omeprazol, spôsob jej prípravy a jej použitie Download PDF

Info

Publication number
SK285326B6
SK285326B6 SK1825-2001A SK18252001A SK285326B6 SK 285326 B6 SK285326 B6 SK 285326B6 SK 18252001 A SK18252001 A SK 18252001A SK 285326 B6 SK285326 B6 SK 285326B6
Authority
SK
Slovakia
Prior art keywords
dosage form
core material
weight
omeprazole
form according
Prior art date
Application number
SK1825-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK18252001A3 (sk
Inventor
Per Johan Lundberg
Brita Sj�Blom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK18252001A3 publication Critical patent/SK18252001A3/sk
Publication of SK285326B6 publication Critical patent/SK285326B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SK1825-2001A 1999-06-22 2000-06-20 Orálna dávková forma obsahujúca omeprazol a S-omeprazol, spôsob jej prípravy a jej použitie SK285326B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9902386A SE9902386D0 (sv) 1999-06-22 1999-06-22 New formulation
PCT/SE2000/001310 WO2000078293A1 (en) 1999-06-22 2000-06-20 New formulation

Publications (2)

Publication Number Publication Date
SK18252001A3 SK18252001A3 (sk) 2002-09-10
SK285326B6 true SK285326B6 (sk) 2006-11-03

Family

ID=20416209

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1825-2001A SK285326B6 (sk) 1999-06-22 2000-06-20 Orálna dávková forma obsahujúca omeprazol a S-omeprazol, spôsob jej prípravy a jej použitie

Country Status (29)

Country Link
EP (1) EP1191926B1 (xx)
JP (1) JP2003502359A (xx)
KR (1) KR100717661B1 (xx)
CN (1) CN1243547C (xx)
AT (1) ATE291901T1 (xx)
AU (1) AU778158B2 (xx)
BR (1) BR0011894A (xx)
CA (1) CA2376226C (xx)
CZ (1) CZ20014579A3 (xx)
DE (1) DE60019116T2 (xx)
DK (1) DK1191926T3 (xx)
EE (1) EE200100693A (xx)
ES (1) ES2235912T3 (xx)
HK (1) HK1044480B (xx)
HU (1) HUP0201489A3 (xx)
IL (2) IL146818A0 (xx)
IS (1) IS6209A (xx)
MX (1) MXPA01012636A (xx)
NO (1) NO20016346L (xx)
NZ (1) NZ516186A (xx)
PL (1) PL352873A1 (xx)
PT (1) PT1191926E (xx)
RU (1) RU2240110C2 (xx)
SE (1) SE9902386D0 (xx)
SK (1) SK285326B6 (xx)
TR (1) TR200103693T2 (xx)
UA (1) UA73302C2 (xx)
WO (1) WO2000078293A1 (xx)
ZA (1) ZA200109803B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
SI21402A (sl) 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
EP1605919A1 (en) * 2003-02-28 2005-12-21 Ranbaxy Laboratories, Ltd. Stable pharmaceutical composition of rabeprazole and processes for their preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005027876A1 (en) * 2003-08-28 2005-03-31 Ranbaxy Laboratories Limited Pharmaceutical compositions of benzimidazole and processes for their preparation
AU2004268383A1 (en) * 2003-09-03 2005-03-10 Agi Therapeutics Limited Proton pump inhibitor formulations, and methods of preparing and using such formulations
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005275594A1 (en) * 2004-08-23 2006-03-02 Synergy Pharmaceuticals Pte Ltd Gastric therapies and compositions therefor
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
SG184754A1 (en) * 2005-12-28 2012-10-30 Takeda Pharmaceutical Controlled release solid preparation
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
DK2046334T3 (da) 2006-07-25 2014-08-25 Vecta Ltd Sammensætninger og fremgangsmåder til at hæmme mavesyresekretion ved at anvende derivater af små dicarboxylsyrer i kombination med PPI
EP2079448A2 (en) * 2006-10-10 2009-07-22 Dexcel Pharma Technologies Ltd. Improved release of statins in the intestine
EP2344139A1 (en) 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
MX353623B (es) * 2011-05-13 2018-01-22 Eb Ip Hybritabs B V Sistema de suministro de farmaco.
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
WO2013122554A1 (en) 2012-02-14 2013-08-22 Mahmut Bilgic Pellet formulations comprising esomeprazole
CN103127026B (zh) * 2013-02-05 2017-02-15 悦康药业集团有限公司 一种奥美拉唑肠溶胶囊及其制备方法
WO2015102745A1 (en) 2013-12-31 2015-07-09 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
RU2614730C1 (ru) * 2016-02-05 2017-03-28 Игорь Юрьевич Чичерин Антибактериальное средство и способ лечения кишечного иерсиниоза, или псевдотуберкулеза, или эшерихиоза
US10736855B2 (en) * 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
JP6426115B2 (ja) * 2016-04-06 2018-11-21 ニプロ株式会社 カルシウムブロッカーを含有する固形医薬組成物
JP6462625B2 (ja) * 2016-04-06 2019-01-30 ニプロ株式会社 カルシウムブロッカーを含有する錠剤
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN109125282B (zh) * 2018-09-05 2020-07-14 珠海润都制药股份有限公司 一种奥美拉唑肠溶胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AU5179898A (en) * 1996-11-06 1998-05-29 Sharmatek, Inc. Delayed delivery system for acid-sensitive drugs
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
PL195266B1 (pl) * 1997-12-08 2007-08-31 Altana Pharma Ag Jednostka związku aktywnego nietrwałego w środowisku kwaśnym, sposób jej otrzymywania, czopki zawierające aktywny związek nietrwały w środowisku kwaśnym oraz sposób ich otrzymywania
JP4988088B2 (ja) * 1998-08-12 2012-08-01 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾール、もしくはピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾールの骨格を有する化合物、またはその薬学的に許容される塩の経口投与形組成物を固定的に組み合わせた組成物

Also Published As

Publication number Publication date
DK1191926T3 (da) 2005-06-13
SE9902386D0 (sv) 1999-06-22
CN1243547C (zh) 2006-03-01
RU2240110C2 (ru) 2004-11-20
EE200100693A (et) 2003-02-17
IL146818A0 (en) 2002-07-25
AU6034400A (en) 2001-01-09
MXPA01012636A (es) 2002-06-21
TR200103693T2 (tr) 2002-05-21
CA2376226A1 (en) 2000-12-28
CN1356893A (zh) 2002-07-03
IS6209A (is) 2001-12-21
SK18252001A3 (sk) 2002-09-10
PT1191926E (pt) 2005-07-29
EP1191926B1 (en) 2005-03-30
CZ20014579A3 (cs) 2002-05-15
CA2376226C (en) 2009-10-20
EP1191926A1 (en) 2002-04-03
AU778158B2 (en) 2004-11-18
HUP0201489A3 (en) 2004-05-28
KR100717661B1 (ko) 2007-05-14
BR0011894A (pt) 2002-04-02
WO2000078293A1 (en) 2000-12-28
KR20020012002A (ko) 2002-02-09
ZA200109803B (en) 2003-02-28
NZ516186A (en) 2003-11-28
HK1044480A1 (en) 2002-10-25
DE60019116D1 (de) 2005-05-04
NO20016346D0 (no) 2001-12-21
ATE291901T1 (de) 2005-04-15
NO20016346L (no) 2002-02-18
PL352873A1 (en) 2003-09-08
HUP0201489A2 (hu) 2002-11-28
UA73302C2 (en) 2005-07-15
HK1044480B (zh) 2005-08-26
IL146818A (en) 2007-10-31
DE60019116T2 (de) 2006-02-09
JP2003502359A (ja) 2003-01-21
ES2235912T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
EP1191926B1 (en) New omeprazole and (s)-omeprazole formulation
KR100616027B1 (ko) 경구용 제약학적 펄스 방출형 투여 제형
CA2290531C (en) Pharmaceutical formulation of omeprazole
JP4638561B2 (ja) プロトンポンプ抑制剤を含有するマルチプルユニットの沸騰剤形
JP4865945B2 (ja) 経口の延長放出性医薬品剤形
RU2361574C2 (ru) Составы пантопразола, состоящие из множества частиц
NZ510993A (en) Pharmaceutical formulation comprising omeprazole, a substituted pyridylsulfinylbenzimidazole a gastric acid secretion inhibitor, where the storage period is extended
SK117097A3 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
AU1214500A (en) Oral pulsed dose drug delivery system
KR20070083956A (ko) 양성자 펌프 억제제를 위한 신규 변형 방출 정제 제형
AU5791900A (en) Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
AU2004200325B2 (en) Oral Pulsed Dose Drug Delivery System
MXPA00005895A (en) Oral pharmaceutical pulsed release dosage form
AU2006236052A1 (en) Oral pulsed dose drug delivery system

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090620